Saturday, August 29, 2026

The Next Trillion-Dollar Bet: Korean Pharma Invests in Immuno-Oncology, Targeting a $1 Trillion Global Market

Cho Yong-joon outlines Dongkoo Bio's transformation into a global healthcare leader, emphasizing convergence and innovative growth strategies.

Why Kim Jong Un Skipped Kim Il Sung’s Birthday Ceremony for the Fourth Year

Kim Jong Un skipped the traditional visit to honor Kim Il Sung for the fourth year, reflecting a shift in North Korea's leadership dynamics.

North Korea’s Mysterious Missile Launch: What Does It Mean for South Korea?

North Korea attempted a missile launch, possibly a ballistic missile, shortly after President Lee's remarks on drone incidents.

Tag: Enblo

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Daewoong Pharma Signs $1.45 Billion MENA Export Deal for ‘Enavogliflozin,’ Marking Record Global Sales

Daewoong Pharmaceutical's diabetes drug Enblo secures a $1.45 billion deal to enter MENA markets, marking a significant milestone.

Daewoong’s Enavogliflozin Shows Consistent Glucose-Lowering Effects Across Korean and Chinese Patients

Daewoong's diabetes drug Enblo shows similar effects in Korean and Chinese patients, supporting its global expansion and future approvals.

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.